Table 2 Population baseline characteristics and CMR parameters in the clinical setting
Parameters | Median (interquartile range) or n (%) |
|---|---|
Clinical | Overall (n = 100) |
Gender, male | 41 (41%) |
Age, years | 61 (53–69) |
Body mass index, kg/m2 | 28 (24–32) |
Body surface area, m2 | 1.9 (1.8–2.1) |
Race, % | Â |
 Black | 42 (42%) |
 White | 44 (44%) |
 Hispanic | 7 (7%) |
 Asian | 5 (5%) |
 Unknown | 2 (2%) |
Diagnosis, n (%) | Â |
 Coronary artery disease | 56 (56%) |
 Hypertension | 81 (81%) |
 Diabetes | 42 (42%) |
 Post-heart transplant | 5 (5%) |
 Post-CABG | 19 (19%) |
 Congenital heart disease | 2 (2%) |
 Pulmonary hypertension | 7 (7%) |
 Chronic lung disease | 25 (25%) |
 Obstructive sleep apnea | 14 (14%) |
 Cardiomyopathy | 39 (39%) |
 ICM | 16 (16%) |
 NICM | 23 (23%) |
CMR | Â |
 LVEDV, ml | 157 (123–205) |
 LVEDVI, ml/m2 | 80 (67–105) |
 LVESV, ml | 80 (52–125) |
 LVESVI, ml/m2 | 40 (27–63) |
 LVM, g | 110 (88–129) |
 LVMI, g/m2 | 56 (46–66) |
 LVEF, % | 49 (39–61) |
 RVEDV, ml | 149 (116–173) |
 RVEDVI, ml/m2 | 75 (62–89) |
 RVESV, ml | 69 (50–95) |
 RVESVI, ml/m2 | 35 (26–49) |
 RVEF, % | 54 (45–58) |
 LGE, n (%) | 43 (43%) |
 Ischemic pattern | 29 (29%) |
 Non-ischemic pattern | 10 (10%) |
 Both patterns | 4 (4%) |